Snore.com
A physician-originated digital asset positioned for AI-mediated health discovery, unbranded disease education, patient triage, pharmacy navigation, and sleep/cardiometabolic care pathways. Own the Symptom → Guide to Your Cure.
Dr. Murray Moffat
Dr. Murray Moffat is a retired physician who restricted his practice to sleep medicine by physician referral only for over 30 years.
Murray’s experience as an Ontario Regional Coroner motivated a career change to sleep medicine, leading to a referral practice spanning three certified Independent Health Facilities, each comprised of a sleep medicine clinic and laboratory.
His expertise bridges clinical practice and regulatory standards. He served as the Co-chair of the inaugural College of Physicians and Surgeons of Ontario Sleep Task Force, developing the Clinical Practice Parameters and Facility Standards for sleep studies in the province.
Registered in 1995, snore.com was not held as an investment; it was utilized as a clinical resource to help build a referral only sleep medicine practice that grew to 3 facilities with 18 beds.
It has been solely owned by Dr. Moffat for three decades, endowing it with a “Trust Signal” that new domains cannot replicate in the eyes of AI search algorithms.
From Search Engine Optimization (SEO)
to AI-Mediated Discovery
Patients and physicians are moving away from clicking links. They now consume answers generated by AI.
In this new ecosystem, generic keywords are less effective. Semantic Authority Prevails.
Traditional SEO Is Diminishing
- Relies on “Keywords” and backlinks.
- Users must click multiple links to find answers.
- Competitors can “buy” their way to the top with ads.
- High bounce rates as users get frustrated.
AI Discovery
- Relies on Authority and Context.
- AI (Gemini, ChatGPT, Copilot) summarizes the “best” answer directly.
- Models prioritize “Category Defining” domains like Snore.com.
- Semantic Match: The domain is the symptom.
Why Snore.com Succeeds in AI Search
Snore.com is more than a domain—it is a global entry point for millions of high-risk patients whose clinical journey begins with a single word.
In the age of LLMs and AI-driven discovery, the path to a clinical solution increasingly starts with a symptom.
Snore.com is uniquely positioned to capture user intent at the point of origin, serving as the ultimate “capture-net” for global, high-risk cardiometabolic cohorts.
- Inherent “exact-match” advantage.
- Direct link between query intent and destination.
- Improves the odds of being surfaced as the “featured” answer.
- One memorable domain organises “all things snoring.”
- Clinician-reviewed content across snoring cohorts.
- Spans sleep apnea, diabetes, vascular health, liver, and kidney disease.
- Symptom-first disease awareness reduces friction.
- Routes users toward evaluation and appropriate care pathways.
- Supports seamless linkage to weight management and physician care.
Strategic Marketing for Snoring Cohorts
Snore.com can be deployed as an unbranded, clinically reviewed disease-awareness gateway across high-value snoring cohorts—OSA, diabetes, hypertension, cardiometabolic, liver, and kidney disease—each mapped to prevalence signals and clear strategic opportunity.